A worse prognosis was observed in patients with HNSCC who exhibited high levels of expression of SEC11A, SC5D, CYB5B, HPRT1, and SLC2A3 and low levels of expression of CORO1A and PIK3R3. This evidence concerns the gene HPRT1 and head and neck squamous cell carcinoma.